Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Research ArticleSpine
Open Access

T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma

P. Santos, K.K. Peck, J. Arevalo-Perez, S. Karimi, E. Lis, Y. Yamada, A.I. Holodny and J. Lyo
American Journal of Neuroradiology November 2017, 38 (11) 2210-2216; DOI: https://doi.org/10.3174/ajnr.A5383
P. Santos
aFrom the Departments of Radiology (P.S., K.K.P., J.A.-P., S.K., E.L., A.I.H., J.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P. Santos
K.K. Peck
aFrom the Departments of Radiology (P.S., K.K.P., J.A.-P., S.K., E.L., A.I.H., J.L.)
bMedical Physics (K.K.P.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for K.K. Peck
J. Arevalo-Perez
aFrom the Departments of Radiology (P.S., K.K.P., J.A.-P., S.K., E.L., A.I.H., J.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. Arevalo-Perez
S. Karimi
aFrom the Departments of Radiology (P.S., K.K.P., J.A.-P., S.K., E.L., A.I.H., J.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S. Karimi
E. Lis
aFrom the Departments of Radiology (P.S., K.K.P., J.A.-P., S.K., E.L., A.I.H., J.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E. Lis
Y. Yamada
cRadiation Oncology (Y.Y.), Memorial Sloan Kettering Cancer Center, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Y. Yamada
A.I. Holodny
aFrom the Departments of Radiology (P.S., K.K.P., J.A.-P., S.K., E.L., A.I.H., J.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for A.I. Holodny
J. Lyo
aFrom the Departments of Radiology (P.S., K.K.P., J.A.-P., S.K., E.L., A.I.H., J.L.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. Lyo
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF
Loading

References

  1. 1.↵
    1. Walcott BP,
    2. Nahed BV,
    3. Mohyeldin A, et al
    . Chordoma: current concepts, management, and future directions. Lancet Oncol 2012;13:e69–76 doi:10.1016/S1470-2045(11)70337-0 pmid:22300861
    CrossRefPubMedWeb of Science
  2. 2.↵
    1. Healey JH,
    2. Lane JM
    . Chordoma: a critical review of diagnosis and treatment. Orthop Clin North Am 1989;20:417–26 pmid:2662114
    PubMedWeb of Science
  3. 3.↵
    1. Stiller CA,
    2. Trama A,
    3. Serraino D, et al
    ; RARECARE Working Group. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer 2013;49:684–95 doi:10.1016/j.ejca.2012.09.011 pmid:23079473
    CrossRefPubMedWeb of Science
  4. 4.↵
    1. McMaster ML,
    2. Goldstein AM,
    3. Bromley CM, et al
    . Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 2001;12:1–11 doi:10.1023/A:1008947301735 pmid:11227920
    CrossRefPubMedWeb of Science
  5. 5.↵
    1. Sung MS,
    2. Lee GK,
    3. Kang HS, et al
    . Sacrococcygeal chordoma: MR imaging in 30 patients. Skeletal Radiol 2005;34:87–94 doi:10.1007/s00256-004-0840-4 pmid:15480648
    CrossRefPubMedWeb of Science
  6. 6.↵
    1. Smolders D,
    2. Wang X,
    3. Drevelengas A, et al
    . Value of MRI in the diagnosis of non-clival, non-sacral chordoma. Skeletal Radiol 2003;32:343–50 doi:10.1007/s00256-003-0633-1 pmid:12719927
    CrossRefPubMed
  7. 7.↵
    1. Rodallec MH,
    2. Feydy A,
    3. Larousserie F, et al
    . Diagnostic imaging of solitary tumors of the spine: what to do and say. Radiographics 2008;28:1019–41 doi:10.1148/rg.284075156 pmid:18635627
    CrossRefPubMedWeb of Science
  8. 8.↵
    1. Llauger J,
    2. Palmer J,
    3. Amores S, et al
    . Primary tumors of the sacrum: diagnostic imaging. AJR Am J Roentgenol 2000;174:417–24 doi:10.2214/ajr.174.2.1740417 pmid:10658718
    CrossRefPubMedWeb of Science
  9. 9.↵
    1. Chugh R,
    2. Tawbi H,
    3. Lucas DR, et al
    . Chordoma: the nonsarcoma primary bone tumor. Oncologist 2007;12:1344–50 doi:10.1634/theoncologist.12-11-1344 pmid:18055855
    Abstract/FREE Full Text
  10. 10.↵
    1. Stacchiotti S,
    2. Sommer J
    . Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol 2015;16:e71–83 doi:10.1016/S1470-2045(14)71190-8 pmid:25638683
    CrossRefPubMed
  11. 11.↵
    1. Fuchs B,
    2. Dickey ID,
    3. Yaszemski MJ, et al
    . Operative management of sacral chordoma. J Bone Joint Surg Am 2005;87:2211–16 pmid:16203885
    Abstract/FREE Full Text
  12. 12.↵
    1. Jackson A,
    2. Buckley D,
    3. Parker G
    1. Parker G,
    2. Buckley D
    . Tracer kinetic modeling for T1-weighted DCE-MRI. In: Jackson A, Buckley D, Parker G. Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology. Berlin: Springer; 2005:81–91
  13. 13.↵
    1. Chu S,
    2. Karimi S,
    3. Peck KK, et al
    . Measurement of blood perfusion in spinal metastases with dynamic contrast-enhanced magnetic resonance imaging: evaluation of tumor response to radiation therapy. Spine 2013;38:E1418–24 doi:10.1097/BRS.0b013e3182a40838 pmid:23873238
    CrossRefPubMed
  14. 14.↵
    1. Saha A,
    2. Peck KK,
    3. Lis E, et al
    . Magnetic resonance perfusion characteristics of hypervascular renal and hypovascular prostate spinal metastases: clinical utilities and implications. Spine 2014;39:E1433–40 doi:10.1097/BRS.0000000000000570 pmid:25188594
    CrossRefPubMed
  15. 15.↵
    1. Lang N,
    2. Su MY,
    3. Xing X, et al
    . Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the axial skeleton. J Magn Reson Imaging 2017;45:1068–75 doi:10.1002/jmri.25414 pmid:27490009
    CrossRefPubMed
  16. 16.↵
    1. Tofts PS,
    2. Brix G,
    3. Buckley DL, et al
    . Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32 pmid:10508281
    CrossRefPubMedWeb of Science
  17. 17.↵
    1. Chen KW,
    2. Yang HL,
    3. Lu J, et al
    . Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma. J Neurooncol 2011;101:357–63 doi:10.1007/s11060-010-0263-0 pmid:20549300
    CrossRefPubMed
  18. 18.↵
    1. Kawashima A,
    2. Okada Y,
    3. Nakanishi I, et al
    . Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. Gen Diagn Pathol 1997;142:129–37 pmid:9065576
    PubMed
  19. 19.↵
    1. Kumta SM,
    2. Huang L,
    3. Cheng YY, et al
    . Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions. Life Sci 2003;73:1427–36 doi:10.1016/S0024-3205(03)00434-X pmid:12850503
    CrossRefPubMedWeb of Science
  20. 20.↵
    1. Kaya M,
    2. Wada T,
    3. Kawaguchi S, et al
    . Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma. Br J Cancer 2002;86:864–69 doi:10.1038/sj.bjc.6600201 pmid:11953816
    CrossRefPubMedWeb of Science
  21. 21.↵
    1. Johnson LM,
    2. Turkbey B,
    3. Figg WD, et al
    . Multiparametric MRI in prostate cancer management. Nature Rev Clin Oncol 2014;11:346–53 doi:10.1038/nrclinonc.2014.69
    CrossRefPubMed
  22. 22.↵
    1. Park HJ,
    2. Griffin RJ,
    3. Hui S, et al
    . Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res 2012;177:311–27 doi:10.1667/RR2773.1 pmid:22229487
    CrossRefPubMed
  23. 23.↵
    1. De Coninck T,
    2. Jans L,
    3. Sys G, et al
    . Dynamic contrast-enhanced MR imaging for differentiation between enchondroma and chondrosarcoma. Eur Radiol 2013;23:3140–52 doi:10.1007/s00330-013-2913-z pmid:23771600
    CrossRefPubMed
  24. 24.↵
    1. Røe K,
    2. Kakar M,
    3. Seierstad T, et al
    . Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study. Radiat Oncol 2011;6:65 doi:10.1186/1748-717X-6-65 pmid:21651782
    CrossRefPubMed
  25. 25.↵
    1. Cao Y
    . The promise of dynamic contrast-enhanced imaging in radiation therapy. Semin Radiat Oncol 2011;21:147–56 doi:10.1016/j.semradonc.2010.11.001 pmid:21356482
    CrossRefPubMed
  26. 26.↵
    1. Grabham P,
    2. Sharma P
    . The effects of radiation on angiogenesis. Vasc Cell 2013;5:1 doi:10.1186/2045-824X-5-19 pmid:24160185
    CrossRefPubMed
  27. 27.↵
    1. Thomas AA,
    2. Arevalo-Perez J,
    3. Kaley T, et al
    . Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma. J Neurooncol 2015;125:183–90 doi:10.1007/s11060-015-1893-z pmid:26275367
    CrossRefPubMed
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 38 (11)
American Journal of Neuroradiology
Vol. 38, Issue 11
1 Nov 2017
  • Table of Contents
  • Index by author
  • Complete Issue (PDF)
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma
P. Santos, K.K. Peck, J. Arevalo-Perez, S. Karimi, E. Lis, Y. Yamada, A.I. Holodny, J. Lyo
American Journal of Neuroradiology Nov 2017, 38 (11) 2210-2216; DOI: 10.3174/ajnr.A5383

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
T1-Weighted Dynamic Contrast-Enhanced MR Perfusion Imaging Characterizes Tumor Response to Radiation Therapy in Chordoma
P. Santos, K.K. Peck, J. Arevalo-Perez, S. Karimi, E. Lis, Y. Yamada, A.I. Holodny, J. Lyo
American Journal of Neuroradiology Nov 2017, 38 (11) 2210-2216; DOI: 10.3174/ajnr.A5383
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • ABBREVIATIONS:
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • MRI Signal Intensity and Electron Ultrastructure Classification Predict the Long-Term Outcome of Skull Base Chordomas
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Spinal Cord Gray and White Matter Damage in Different Hereditary Spastic Paraplegia Subtypes
  • Cervical Spinal Cord Compression and Sleep-Disordered Breathing in Syndromic Craniosynostosis
  • Decubitus CT Myelography for CSF-Venous Fistulas: A Procedural Approach
Show more SPINE

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2020 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2021 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire